Indaptus Therapeutics, Inc. (INDP)
2.82
-0.31
(-9.90%)
USD |
NASDAQ |
Nov 20, 12:22
Indaptus Therapeutics Cash from Operations (Quarterly) : -1.245M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.245M |
| June 30, 2026 | -2.157M |
| March 31, 2026 | -7.01M |
| December 31, 2025 | -3.558M |
| September 30, 2025 | -3.060M |
| June 30, 2025 | -4.056M |
| March 31, 2025 | -5.047M |
| December 31, 2024 | -3.422M |
| September 30, 2024 | -2.531M |
| June 30, 2024 | -2.425M |
| March 31, 2024 | -3.936M |
| December 31, 2023 | -2.472M |
| September 30, 2023 | -3.507M |
| June 30, 2023 | -1.993M |
| March 31, 2023 | -4.962M |
| December 31, 2022 | -2.055M |
| September 30, 2022 | -4.413M |
| June 30, 2022 | -3.007M |
| March 31, 2022 | -3.118M |
| December 31, 2021 | -3.761M |
| September 30, 2021 | -5.678M |
| June 30, 2021 | -1.298M |
| March 31, 2021 | -0.8256M |
| December 31, 2020 | -1.024M |
| September 30, 2020 | 4.397M |
| Date | Value |
|---|---|
| June 30, 2020 | -1.658M |
| March 31, 2020 | -5.147M |
| December 31, 2019 | -5.186M |
| September 30, 2019 | -6.595M |
| June 30, 2019 | -10.58M |
| March 31, 2019 | -7.262M |
| December 31, 2018 | -7.658M |
| September 30, 2018 | -10.74M |
| June 30, 2018 | -9.280M |
| March 31, 2018 | -10.26M |
| December 31, 2017 | -7.172M |
| September 30, 2017 | -6.432M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -4.258M |
| September 30, 2015 | -0.26M |
| June 30, 2015 | -1.691M |
| March 31, 2015 | -1.734M |
| December 31, 2014 | -1.064M |
| September 30, 2014 | -1.221M |
| June 30, 2014 | -0.8869M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | -2.902M |
| Capricor Therapeutics, Inc. | -35.69M |
| Ocugen, Inc. | -15.74M |
| Cue Biopharma, Inc. | -10.08M |
| Yarrow Bioscience, Inc. | -89.96M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.0882M |
| Cash from Financing (Quarterly) | 20.30M |
| Free Cash Flow | -13.97M |
| Free Cash Flow Per Share (Quarterly) | -0.0093 |
| Free Cash Flow to Equity (Quarterly) | -1.245M |
| Free Cash Flow to Firm (Quarterly) | -1.245M |
| Free Cash Flow Yield | -3.72% |